RPS6KA2 and triple-negative breast carcinoma: In triple-negative breast cancer (TNBC), MYSM1 reduces RSK3 protein to inactive RSK3-phospho-BAD pathway and induces apoptosis and cisplatin sensitivity (Guan et al, 2022).